Nikolaus Sarafoff

Summary

Publications

  1. doi request reprint Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation
    Nikolaus Sarafoff
    Klinikum der Ludwig Maximilians Universität München, Medizinische Klinik und Poliklinik I, Munich, Germany
    J Am Coll Cardiol 61:2060-6. 2013
  2. doi request reprint Association of ST-elevation and non-ST-elevation presentation on ECG with transmurality and size of myocardial infarction as assessed by contrast-enhanced magnetic resonance imaging
    Nikolaus Sarafoff
    Klinik für Herz und Kreislauferkrankungen, Deutsches Herzzentrum, Technical University Munich, Germany
    J Electrocardiol 46:100-6. 2013
  3. ncbi request reprint Clinical use of clopidogrel
    Nikolaus Sarafoff
    Deutsches Herzzentrum, Technische Universität Munich, Germany
    Curr Pharm Des 18:5224-39. 2012
  4. doi request reprint Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting
    Nikolaus Sarafoff
    Deutsches Herzzentrum Munchen, Munich, Germany
    Am Heart J 161:605-10. 2011
  5. ncbi request reprint Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-
    K Anette Fiedler
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany DZHK German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Munich, Germany Electronic address
    Am Heart J 167:459-465.e1. 2014
  6. doi request reprint Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel
    Dirk Sibbing
    Deutsches Herzzentrum and 1 Medizinische Klinik rechts der Isar, Technische Universitat Munchen, Lazarettstrasse, Munich, Germany
    Eur Heart J 31:1205-11. 2010
  7. doi request reprint Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors
    Nikolaus Sarafoff
    Deutsches Herzzentrum Munchen, Klinik für Herz und Kreislauferkrankungen Lazarettstr 3680636 Munich, Germany
    Thromb Haemost 104:626-32. 2010
  8. doi request reprint Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment
    Robert A Byrne
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    Drug Saf 32:749-70. 2009

Collaborators

Detail Information

Publications8

  1. doi request reprint Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation
    Nikolaus Sarafoff
    Klinikum der Ludwig Maximilians Universität München, Medizinische Klinik und Poliklinik I, Munich, Germany
    J Am Coll Cardiol 61:2060-6. 2013
    ..This study sought to evaluate whether prasugrel may serve as an alternative to clopidogrel in patients with triple therapy...
  2. doi request reprint Association of ST-elevation and non-ST-elevation presentation on ECG with transmurality and size of myocardial infarction as assessed by contrast-enhanced magnetic resonance imaging
    Nikolaus Sarafoff
    Klinik für Herz und Kreislauferkrankungen, Deutsches Herzzentrum, Technical University Munich, Germany
    J Electrocardiol 46:100-6. 2013
    ..This association, however, derives primarily from post mortem studies...
  3. ncbi request reprint Clinical use of clopidogrel
    Nikolaus Sarafoff
    Deutsches Herzzentrum, Technische Universität Munich, Germany
    Curr Pharm Des 18:5224-39. 2012
    ....
  4. doi request reprint Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting
    Nikolaus Sarafoff
    Deutsches Herzzentrum Munchen, Munich, Germany
    Am Heart J 161:605-10. 2011
    ..The aim of this study was to assess the impact of CCB therapy on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stent placement...
  5. ncbi request reprint Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen-Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting (ISAR-
    K Anette Fiedler
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany DZHK German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Munich, Germany Electronic address
    Am Heart J 167:459-465.e1. 2014
    ....
  6. doi request reprint Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel
    Dirk Sibbing
    Deutsches Herzzentrum and 1 Medizinische Klinik rechts der Isar, Technische Universitat Munchen, Lazarettstrasse, Munich, Germany
    Eur Heart J 31:1205-11. 2010
    ..The aim of this study was to investigate the impact of phenprocoumon on the antiplatelet effects of clopidogrel in patients with coronary artery disease...
  7. doi request reprint Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors
    Nikolaus Sarafoff
    Deutsches Herzzentrum Munchen, Klinik für Herz und Kreislauferkrankungen Lazarettstr 3680636 Munich, Germany
    Thromb Haemost 104:626-32. 2010
    ..The higher mortality is probably due to confounding as patients on PPIs had a higher risk profile at baseline...
  8. doi request reprint Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment
    Robert A Byrne
    Deutsches Herzzentrum, Technische Universitat, Munich, Germany
    Drug Saf 32:749-70. 2009
    ..On the balance of benefit and risk data available, DES implantation should be the preferred approach across the spectrum of patients with obstructive coronary disease who require PCI therapy...